| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/16/2004 | CN1505614A Process for making amlodipine maleate |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505609A Compound useful as intermediates for cholesteryl ester transfer protein (CETP) inhibitors |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1505603A Substituted benzoic ac id derivatives exhibiting nf-ª—b inhibiting activity |
| 06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
| 06/16/2004 | CN1505524A Immunopotentiators |
| 06/16/2004 | CN1505521A Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 06/16/2004 | CN1505520A Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 06/16/2004 | CN1505519A Amphotericin B aqueous composition |
| 06/16/2004 | CN1505518A Use of sucralfate for the treatment of cervical erosion |
| 06/16/2004 | CN1505517A Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 06/16/2004 | CN1505516A Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 06/16/2004 | CN1505515A Oral pharmaceutical composition of cefpodoxime proxetil |
| 06/16/2004 | CN1505514A Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 06/16/2004 | CN1505513A Aqueous cilostazol preparation for injection |
| 06/16/2004 | CN1505512A A stable pharmaceutical formulation comprising torsemide modification II |
| 06/16/2004 | CN1505511A Use of pyridoindolone derivatives for preparing medicines |
| 06/16/2004 | CN1505510A Medicine combinations using pyridoindolone derivatives and anticancer agent as base |
| 06/16/2004 | CN1505509A Method for treating allergies using substituted pyrazoles |
| 06/16/2004 | CN1505508A Carbamate compounds for use in preventing or treating movement disorders |
| 06/16/2004 | CN1505507A Carbamate compounds for use in preventing or treating psychotic disorders |
| 06/16/2004 | CN1505506A Carbamate compounds for use in preventing or treating bipolar disorder |
| 06/16/2004 | CN1505505A Composition for administration to mucosa and containing coenzyme Q as active ingredient |
| 06/16/2004 | CN1505503A Method for preparing submicron particle suspensions |
| 06/16/2004 | CN1505502A Fibrate-statin combinations with reduced fed-fasted effects |
| 06/16/2004 | CN1505498A Composition for hair and/or scalp |
| 06/16/2004 | CN1505478A Virucidal compositions |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504478A Burnet general saponin extract , its preparation method and use |
| 06/16/2004 | CN1504476A Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof |
| 06/16/2004 | CN1504475A Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof |
| 06/16/2004 | CN1504465A Taxotere trihydrate |
| 06/16/2004 | CN1504462A Pyrimidinyl derivatives as interleukin inhibitors |
| 06/16/2004 | CN1504453A 1,5-double substituted anthraquinone derivative, synthetic method and uses thereof |
| 06/16/2004 | CN1504235A Tie2 receptor-induced gene transfer system for treating target tumor genes |
| 06/16/2004 | CN1504218A Medicine composition for tumour and its preparation method |
| 06/16/2004 | CN1504208A Gingko drop pill for prevention and treatment of cardiovascular and cerebrovascular disease |
| 06/16/2004 | CN1504200A Red-legged disease, curlworm disease ecotype, immunity and prevention and cure technique of eelworm |
| 06/16/2004 | CN1504196A Use of glycyrrhizin and its derivatives as mcp-1 production inhibitors |
| 06/16/2004 | CN1504195A Liposome injection liquid of hydrochloric acid daunerubicin and its process |
| 06/16/2004 | CN1504194A Gen-seng drop pill for promoting immunological function |
| 06/16/2004 | CN1504193A Drug composition containing dioxide fluosulfocytosine, lamivudine and Adefovir dipivoxil |
| 06/16/2004 | CN1504192A Powder and injection preparation of pharmaceutical composition for curing organic phosphorus compound poisoning |
| 06/16/2004 | CN1504191A Cucurbitacin lipsome preparation method and formulation |
| 06/16/2004 | CN1504190A Pharmaceutical composition containing levo-histidine for treating diabetes |
| 06/16/2004 | CN1504189A PDT composition containing benzo porphyrin compound and preparation method |
| 06/16/2004 | CN1504188A Use of 5-hydroxymethyl furfural in preparation of medicine and healthcare product for prevention and treatment of degenerative disease of nervous system and cognize hurt |
| 06/16/2004 | CN1504187A Pharmaceutical composition containing fenofibrate with high efficacy for hyperlipemia, its preparation method and use |
| 06/16/2004 | CN1504186A Large volume injection liquid of ethylenediamine diaceturate and its preparation method |
| 06/16/2004 | CN1504185A 药物组合物 The pharmaceutical composition of |
| 06/16/2004 | CN1504128A Nutritious drinking water containing nicotinic acid for infant |
| 06/16/2004 | CN1504127A Nutritious drinking water containing ferric lactate for infant |
| 06/16/2004 | CN1504125A Drinking water containing lysine for infant< |
| 06/16/2004 | CN1504123A Nutritious drinking water containing vitamin D for infant |
| 06/16/2004 | CN1504122A Nutritious drinking water containing lecithin for infant |
| 06/16/2004 | CN1504121A Nutritious drinking water containing vitamin A for infant |
| 06/16/2004 | CN1504120A Drinking water containing glutamic acid for infant |
| 06/16/2004 | CN1504119A Nutritious liquid containing calcium for children |
| 06/16/2004 | CN1153778C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 06/16/2004 | CN1153773C Salts of optically active sulfoxide derivative |
| 06/16/2004 | CN1153771C Benzofuran-[3,4-f] quinoline derivatives, combination containing the same and application thereof |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153766C Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 06/16/2004 | CN1153765C 4-aryl-1-phenylalkyl-1,2,3,6-Tetrahydropyridines having neurotrophic and neuroprotective activity |
| 06/16/2004 | CN1153764C Substituted benzylaminopiperidine compounds |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/16/2004 | CN1153606C Chelate-forming filter, process for producing the same, and method of purifying liquid with the filter |
| 06/16/2004 | CN1153588C Dialysis fluid containing peptides as osmotic agents obtained from casein and bicarbonate ions as buffering agents |
| 06/16/2004 | CN1153586C Composition for increasing egg-laying rate of hen |
| 06/16/2004 | CN1153583C Medicine for bone injury |
| 06/16/2004 | CN1153580C Traditional Chinese medicine for treating lymph tuberculosis |
| 06/16/2004 | CN1153577C Phospholipid capsule preparation |
| 06/16/2004 | CN1153576C Composition and method for treating bladder cancer |
| 06/16/2004 | CN1153571C External therapeutic composition for dermatitis |
| 06/16/2004 | CN1153570C Method and composition of an oral preparation of itraconazole |
| 06/16/2004 | CN1153569C Use of fumaric acid derivatives |
| 06/16/2004 | CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders |
| 06/16/2004 | CN1153567C Scale production method of forming microparticles |
| 06/16/2004 | CN1153565C Physically active antimicrobial gel for cosmetic products |
| 06/16/2004 | CN1153563C Antioxidant preparation for buccal use |
| 06/16/2004 | CA2465554A1 Quinoline derivatives as probes for the diagnosis of diseases in which tau protein accumulates |
| 06/15/2004 | US6750360 Lipoxin compounds and their use in treating cell proliferative disorders |
| 06/15/2004 | US6750358 5-bromo or 5-chloro1-(3-(dimethylamino)propyl)-1-(4-fluoro phenyl)-1,3-dihydroisobenzofuran reacted with a cyanide source in the presence of a nickel catalyst; antidepressants |
| 06/15/2004 | US6750350 Therapy for sexual disorders |
| 06/15/2004 | US6750349 Superior gastrokinetic properties |
| 06/15/2004 | US6750340 Bisphosphonate conjugates and methods of making and using the same |
| 06/15/2004 | US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample |
| 06/15/2004 | US6750323 Platelet activation protein |
| 06/15/2004 | US6750255 Calcium receptor-active compounds |
| 06/15/2004 | US6750254 Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/15/2004 | US6750253 Aminobenzophenones as inhibitors of il-1β and tnf-α |
| 06/15/2004 | US6750252 Tri-substituted phenyl derivatives and analogues |
| 06/15/2004 | US6750251 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer |
| 06/15/2004 | US6750250 Dry eye, also known generically as keratoconjunctivitis sicca, is a common ophthalmological disorder affecting millions |
| 06/15/2004 | US6750249 Gradually release esculetin or its derivative in a controlled manner over a long period of time |
| 06/15/2004 | US6750247 Lipoxygenase inhibitors; plant extracts |
| 06/15/2004 | US6750246 C-4 carbonate taxanes |
| 06/15/2004 | US6750245 C7 carbamate substituted taxanes |
| 06/15/2004 | US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |